NASDAQ:XAIRBeyondAirInc . Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding BeyondAirInc . Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $6.69 -0.23 (-3.32 %) (As of 07/10/2020 02:51 PM ET) Add Compare Share Today's Range$6.69Now: $6.69▼$7.0050-Day Range$6.44MA: $7.21▼$8.4252-Week Range$3.45Now: $6.69▼$12.50Volume4,045 shsAverage Volume368,175 shsMarket Capitalization$112.66 millionP/E RatioN/ADividend YieldN/ABeta-0.6 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) delivery systems to treat respiratory tract infections and other diseases. Its NO delivery systems are used for the treatment of pulmonary hypertension of the newborn, bronchiolitis, and nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. The company is based in Garden City, New York.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingBeyondAirInc . has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $9.00, BeyondAirInc . has a potential upside of 34.3% from its current price of $6.70.Amount of Analyst CoverageBeyondAirInc . has only been the subject of 1 research reports in the past 90 days. Previous Next 2.8 Community Rank Outperform VotesBeyondAirInc . has received 25 “outperform” votes. (Add your “outperform” vote.)Underperform VotesBeyondAirInc . has received 19 “underperform” votes. (Add your “underperform” vote.)Community SentimentBeyondAirInc . has received 56.82% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about BeyondAirInc . and other stocks. Vote “Outperform” if you believe XAIR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe XAIR will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldBeyondAirInc . does not currently pay a dividend.Dividend GrowthBeyondAirInc . does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, BeyondAirInc . insiders have bought more of their company's stock than they have sold. Specifically, they have bought $260,750.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 18.05% of the stock of BeyondAirInc . is held by insiders.Percentage Held by InstitutionsOnly 10.76% of the stock of BeyondAirInc . is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for BeyondAirInc . are expected to grow in the coming year, from ($1.21) to ($0.68) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of BeyondAirInc . is -3.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BeyondAirInc . is -3.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBeyondAirInc . has a P/B Ratio of 5.40. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.99 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:XAIR Previous Symbol CUSIPN/A CIKN/A Webwww.ait-pharm.com Phone516-665-8200Debt Debt-to-Equity Ratio0.24 Current Ratio5.48 Quick Ratio5.48Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$1.39 million Price / Sales81.05 Cash FlowN/A Price / Cash FlowN/A Book Value$1.24 per share Price / Book5.40Profitability EPS (Most Recent Fiscal Year)($1.53) Net Income$-19,940,000.00 Net Margins-203.22% Return on Equity-162.21% Return on Assets-103.05%Miscellaneous Employees18 Outstanding Shares16,840,000Market Cap$112.66 million Next Earnings Date8/12/2020 (Estimated) OptionableNot Optionable NASDAQ:XAIR Rates by TradingView Receive XAIR News and Ratings via Email Sign-up to receive the latest news and ratings for XAIR and its competitors with MarketBeat's FREE daily newsletter. BeyondAirInc . (NASDAQ:XAIR) Frequently Asked Questions How has BeyondAirInc .'s stock been impacted by COVID-19 (Coronavirus)? BeyondAirInc .'s stock was trading at $5.32 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, XAIR shares have increased by 25.9% and is now trading at $6.70. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of BeyondAirInc .? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BeyondAirInc . in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for BeyondAirInc .. When is BeyondAirInc .'s next earnings date? BeyondAirInc . is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for BeyondAirInc .. How were BeyondAirInc .'s earnings last quarter? BeyondAirInc . (NASDAQ:XAIR) issued its quarterly earnings data on Monday, June, 22nd. The company reported ($0.36) earnings per share for the quarter, missing analysts' consensus estimates of ($0.35) by $0.01. The business earned ($0.20) million during the quarter, compared to analysts' expectations of $0.45 million. BeyondAirInc . had a negative return on equity of 162.21% and a negative net margin of 203.22%. View BeyondAirInc .'s earnings history. What price target have analysts set for XAIR? 1 brokerages have issued 1-year price targets for BeyondAirInc .'s shares. Their forecasts range from $9.00 to $9.00. On average, they anticipate BeyondAirInc .'s stock price to reach $9.00 in the next year. This suggests a possible upside of 34.3% from the stock's current price. View analysts' price targets for BeyondAirInc .. Has BeyondAirInc . been receiving favorable news coverage? News articles about XAIR stock have been trending somewhat positive on Friday, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. BeyondAirInc . earned a news impact score of 1.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about BeyondAirInc .. Who are some of BeyondAirInc .'s key competitors? Some companies that are related to BeyondAirInc . include SI-Bone (SIBN), Antares Pharma (ATRS), Repro Med Systems (KRMD), AngioDynamics (ANGO), Cytosorbents (CTSO), Repro-Med Systems (REPR), Utah Medical Products (UTMD), Iradimed (IRMD), Alphatec (ATEC), SeaSpine (SPNE), Pulse Biosciences (PLSE), Westaim (WEDXF), Liquidia Technologies (LQDA), iCAD (ICAD) and RenovaCare (RCAR). View all competitors. What other stocks do shareholders of BeyondAirInc . own? Based on aggregate information from My MarketBeat watchlists, some companies that other BeyondAirInc . investors own include Inovio Pharmaceuticals (INO), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), NovaBay Pharmaceuticals (NBY), Opko Health (OPK), ACADIA Pharmaceuticals (ACAD), Achillion Pharmaceuticals (ACHN), Aerie Pharmaceuticals (AERI) and Ardelyx (ARDX). Who are BeyondAirInc .'s key executives? BeyondAirInc .'s management team includes the following people: Mr. Steven Adam Lisi, CEO & Chairman (Age 48)Mr. Amir Avniel, Co-Founder, Pres, COO & Director (Age 45)Mr. Douglas J. Beck CPA, Chief Financial Officer (Age 58)Mr. Adam Newman, Chief Legal Officer & Gen. CounselMr. Duncan Fatkin, Chief Commercial Officer What is BeyondAirInc .'s stock symbol? BeyondAirInc . trades on the NASDAQ under the ticker symbol "XAIR." How do I buy shares of BeyondAirInc .? Shares of XAIR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is BeyondAirInc .'s stock price today? One share of XAIR stock can currently be purchased for approximately $6.70. How big of a company is BeyondAirInc .? BeyondAirInc . has a market capitalization of $112.83 million and generates $1.39 million in revenue each year. The company earns $-19,940,000.00 in net income (profit) each year or ($1.53) on an earnings per share basis. BeyondAirInc . employs 18 workers across the globe. What is BeyondAirInc .'s official website? The official website for BeyondAirInc . is www.ait-pharm.com. How can I contact BeyondAirInc .? BeyondAirInc .'s mailing address is 825 EAST GATE BOULEVARD SUITE 320, GARDEN CITY NY, 11530. The company can be reached via phone at 516-665-8200. This page was last updated on 7/10/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
